| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $32.79 ▲ +2.03% | Yesterday | $31.87 ▼ -0.85% | Tomorrow's Harmony Biosciences Holdings Inc. Common Stock (HRMY) setup is anchored to $32.14 and targets $32.79 (+2.03%). The near-term read is upside; watch $33.10 / $31.18 because daily realized volatility is about 8.00%. |
Tomorrow's Harmony Biosciences Holdings Inc. Common Stock (HRMY) setup is anchored to $32.14 and targets $32.79 (+2.03%). The near-term read is upside; watch $33.10 / $31.18 because daily realized volatility is about 8.00%. | ||||
| Week | $34.17 ▲ +6.31% | Last Week | $31.29 ▼ -2.65% | The 7-day Harmony Biosciences Holdings Inc. Common Stock model moves from $31.29 to $34.17 (+6.31%). It gives upside momentum context for this stock, so breaks around $33.10 / $31.18 matter more than a single tick. |
The 7-day Harmony Biosciences Holdings Inc. Common Stock model moves from $31.29 to $34.17 (+6.31%). It gives upside momentum context for this stock, so breaks around $33.10 / $31.18 matter more than a single tick. | ||||
| Month | $36.46 ▲ +13.45% | Last Month | $30.32 ▼ -5.65% | The 1-month Harmony Biosciences Holdings Inc. Common Stock target is $36.46 (+13.45%), compared with the live reference near $32.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Harmony Biosciences Holdings Inc. Common Stock target is $36.46 (+13.45%), compared with the live reference near $32.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $39.90 ▲ +24.14% | Last Year | $28.88 ▼ -10.14% | The 1-year Harmony Biosciences Holdings Inc. Common Stock scenario points to $39.90 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Harmony Biosciences Holdings Inc. Common Stock scenario points to $39.90 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $47.95 ▲ +49.20% | 5 Years Ago | $25.50 ▼ -20.66% | The 5-year Harmony Biosciences Holdings Inc. Common Stock view is $47.95 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Harmony Biosciences Holdings Inc. Common Stock view is $47.95 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $32.14 | Mid |
| Daily Change | +8.84% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 76% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $32.14 | Daily Change | +8.84% |
| Market Cap | $1.86B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.